
Acute zzso leukemia zzso remains the most common form of leukemia and the most common cause of leukemia zzso Although conventional chemotherapy can cure between 25 and zzso of zzso patients, most patients will either die of zzso or die from the complications associated with zzso Thus, more specific and less toxic treatments for zzso patients are zzso Recently, a small molecular inhibitor zzso or zzso that targets the zzso gene was found to have a dramatic clinical effect in patients with chronic zzso leukemia zzso These results have encouraged investigators to search for additional small molecular zzso and other targeted therapies that may be zzso to other forms of zzso In this review, we examine some of the signaling pathways that are zzso regulated in zzso focusing on the zzso zzso zzso and zzso zzso After reviewing these two zzso we explore some of the targeted therapies directed at these pathways that are under development for zzso many of which are already in clinical zzso 

